Calidi Biotherapeutics
在场
Calidi Biotherapeutics 是一家在股票代码 CLDI (US) 下上市的公司。
高管
查看带有其 17 名主要高管的组织结构图
Calidi Biotherapeutics 搜索最多的简介
- Allan Camaisa, Chairman of the Board and Chief Executive Officer
- George Ng, Director
- Scott Leftwich, Director
高管在Calidi Biotherapeutics变化
- George Peoples已作为Director加入公司 (新闻发布的2024六月27号).
创建提醒
跟踪 Calidi Biotherapeutics 的高管变动
生物技术
Calidi Biotherapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Calidi Biotherapeutics 的最新新闻稿
- Transforming all Tumor Sites: The Power of Systemic Enveloped Virotherapy | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Proposed Public Offering | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor | Newsroom - Calidi Biotherapeutics
- View more press releases Close
通过电子邮件
